Alzheimer's disease Trials in Cordova, United States
Conditions / Alzheimer's disease / Cordova, United States
Research into Alzheimer's disease spans multiple therapeutic approaches and trial phases.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05531526 | Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04339413 | A Study to Evaluate the Safety and Tolerability of Long-term Administration of Gantenerumab in Participants With Alzheimer's Disease (AD) | TERMINATED | PHASE3 |
| NCT06808984 | Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease | RECRUITING | PHASE2 |
| NCT00912288 | A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease | TERMINATED | PHASE3 |
| NCT06881836 | A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT05026866 | A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00667810 | Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients | TERMINATED | PHASE3 |
| NCT02951598 | A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD) | ACTIVE_NOT_RECRUITING | — |
| NCT04437511 | A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06335173 | A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD) | ACTIVE_NOT_RECRUITING | PHASE2 |